

Snoring & Sleep Apnea
Insomnia
Narcolepsy
RLS / PLMD
Children′s Disorders
Idiopathic Hypersomnia
Parasomnias
Fibromyalgia
Circadian Rhythm Disorders
Sleep Industry News
Log In to Chat Now!
Chat Calendar
Meet Your Chat Hosts
Chat FAQs
Subscribe or Unsubscribe to Chat Reminder
Chat Technical Help
SeQual Technologies
Puritan Bennett
Respironics
Quietsleep
ResMed
National Fibromyalgia Association
PAPillow
Our Mission & History
President′s Message
Medical Advisory Team
Management Team
Chat Hosts
Privacy Policy
Terms of Service
Contact Us
Feedback







With the release of a new sleeping pill called Lunesta to pharmacies around the United States in the near future, insomnia is receiving significant media attention. It will also receive increased attention through direct advertising to consumers by the companies that market Lunesta and its chief competitor, Ambien. As a result, it is essential that individuals with insomnia know the advantages and disadvantages of sleeping pills and the primary non-drug therapy for insomnia, called cognitive-behavioral therapy, or CBT for short. Like sleeping pills, CBT has received increased attention in the media recently due to the increasing recognition that it represents a viable alternative to sleeping pills. Exactly what are the relative benefits and limitations of these two approaches to treating insomnia?
Both CBT and sedative-hypnotic treatment have been shown to be effective for treating chronic insomnia. Both appear to be equally effective in the short-term (4-6 weeks) for treating sleep maintenance insomnia whereas CBT has been shown to be more effective for treating sleep onset insomnia over 4-6 weeks or longer. Sleeping pills appear to produce more immediate therapeutic effects whereas CBT produces better long term, durable effects.
Lunesta is the first sleeping pill that has been shown to be effective for up to 6 months of nightly use although the therapeutic effects after months are modest compared to placebo. Specifically, it only helps patients fall asleep 15-20 minutes faster than a placebo pill after 6 months of nightly use; and, patients still require 45-50 minutes to fall asleep after treatment and therefore still have significant insomnia.
Overall, newer generation non-benzodiazepine sleeping pills such as Ambien, Sonata, and Lunesta are safer than traditional benzodiazepines, which have many potential side effects with regular use that can outweigh benefits. For these reasons, non-benzodiazepine sleeping pills are the best choice for insomnia. It is important to note that intermittent, non-nightly use of hypnotics minimizes side effects and maintains efficacy over longer periods of time.
There appear to be several advantages of hypnotics over CBT, including the following:
The drawbacks of hypnotics include the following:
The advantages of CBT over hypnotics include the following:
The disadvantages of CBT compared to hypnotics include the following:
When considering treatment options for chronic insomnia, the relative benefits and limitations of both sleeping pills and hypnotics must be considered by both the patient and the primary care physician. The good news is that, with increasing awareness of treatment options that are available for insomnia, more patients with insomnia will be diagnosed and treated effectively.
Read more in the Insomnia Corner.
© 2000-2008 TALK ABOUT SLEEP, INC. ALL RIGHTS RESERVED.
Talk About Sleep, Inc.
14480 Ewing Ave So. Suite 102
Burnsville, MN 55306
Telephone (952) 358-7070
Fax (952) 358-7077